Strengthening HIV Prevention Efforts for Women in the Southern U.S. (R01 Clinical Trial Optional)

Funding Agency:
National Institutes of Health

This Funding Opportunity Announcement (FOA) invites applications for Research Project Grants (R01) that will increase the use of HIV prevention strategies among women in the southern U.S. by elucidating barriers and facilitators to their utilization and developing and testing interventions to enhance uptake, adherence, and persistence. Research should focus on strategies within the following three potentially overlapping areas: implementation science, health communication research, and services research.

This FOA uses the R01 grant mechanism, while RFA-MH-21-150 uses the R34 mechanism. Applications with preliminary data and/or those including longitudinal analysis should consider using the R01 mechanism. Applicants proposing to develop and pilot test an intervention should consider the R34 mechanism.

Deadlines:

  • Letter of Intent Due Date(s): December 11, 2020
  • AIDS Application Due Date(s): January 11, 2021

RFA-MH-21-151 Expiration Date January 12, 2021

Agency Website

Areas of Interest

Research applications should focus on innovative strategies within the following three potentially overlapping areas:

  • Implementation science research to better understand how to scale up HIV prevention for women;
  • Health communication research, including mass media and strategic communication approaches to improve awareness and uptake of HIV prevention strategies;
  • Services research to improve access, engagement, and the equitable distribution of HIV prevention services.

Funding Type

Grant

Eligibility

Faculty

Category

Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

January 11, 2021